nets:

Gain insights from collaborative networks of industry leaders

Introducing the Navitas Life Sciences portfolio of industry leading networks

Joining one of our industry leading networks can help to raise the profile of both your company and your team. Join your peers and be part of an independent sounding board where you can test and validate the latest thinking, and uncover industry insight to develop compelling, yet pragmatic strategies to provide business value and meet the needs of patients, payers, and prescribers.

Our nets community is the place to discuss trends, insights, and future solutions. The philosophy behind each network is to

  • nets

    Provide a platform for industry peers to learn and share from one another in an open environment

  • benchmark

    Deliver benchmark information to compare and measure operational and organisational performance

  • key issues

    Discuss key issues facing organisations with ‘hot topics’ addressed by action teams

  • best-practice

    Regular forums to derive best practices to develop innovative future solutions to tackle shared challenges

  • insights

    Provide access to the latest industry insights through webcasts, think tanks, and community exchange

  • compare-and-improve

    Offer satellite working sessions to surface industry trends and explore future strategies to boost performance and success

Aimed at pharmaceutical industry professionals, the networks were founded as an independent community for business leaders facing similar challenges to have a peer network to exchange insights, compare performance, and debate strategies to tackle the latest hot issues. Each network has a focused and evolving agenda to meet the latest challenges.

Please click below to find the latest topics being debated in your area of interest

pvnet

For Heads of Safety of Top 30 Life Sciences companies; invests in thought leadership to help shape future practices

pvconnect

For Heads of Safety of mid-sized Life Sciences companies with a range of product portfolios including one or more of Pharma, Biologicals, Consumer, and Medical Devices

pvtech

For Heads of Information Technology for PV departments, focused on increasing business value from technology investments

pvindia

For PV leads of Life Sciences companies in the APAC region with Pharma, Consumer, Generics, or mixed portfolios


rim

For Global Heads of RA and RIM IT professionals to create transformational enterprise solutions for Regulatory Information Management

labelnet

For Labeling Leaders of Life Sciences companies; focused on leveraging strategic value from E2E Labeling, with spotlight on strategy and labeling futures

labelconnect

For Labeling Leaders of Life Sciences companies with a specific focus on operational aspects of the full lifecycle of E2E labeling

labeltech

For Regulatory or Labeling IT Professionals; focused on exploring E2E Labeling technologies to improve processes and increase business value


cmonet

For Chief Medical Officers; addressing strategic and governance topics within the remit of the CMO

clinicalnet

For Heads of Clinical Operations, focused on sharing best practice to define excellence in delivery of clinical trials


Nets Newsfeed

Navitas Life Sciences’ 7th pvindia Forum takes place in Mumbai, March, 2019

26 delegates from 14 companies convened at pvindia for the 7th forum on Pharmacovigilance (PV) in Mumbai on March 6th. Throughout the day there was good and lively participation with a high level of engagement and interaction.

Key areas of interest for the participating companies included Safety Data Exchange Agreements, Pharmacovigilance System Master File, Brexit, PV Process Services, and PV Technology. Key priorities include Brexit readiness, PSMF readiness, SDEA process and technology, as well as PV automation.

The attendees learned about the latest global regulatory perspectives – post Brexit regulations of MHRA, EMA’s HQ movement to Amsterdam causing delays in response times, Mexico posing challenges with respect to RMP/RMA, new ROW authorities like Oman tightening their regulations, Ukraine trying to adapt EU standards, challenges associated with importing EVDAS data, and so on.

A session on ‘PV Today – Moving towards operational excellence’ comprised of a presentation by Bristol Labs on ‘Planning to be PSMF ready’ followed by a panel discussion lead by Piramal and Advanz Pharma - the session addressed the planning and managing of safety database upgrades including IDMP compliance, PSMF readiness, and saw time set aside for a roundtable discussion to share and build best practice on Safety Data Exchange Agreements and compliance with global regulations.

The day concluded with a session exploring the PV Vision 2025 – continuing the forward looking journey, led by an introduction from Navitas on trends in PV automation, followed by a member presentation by Novo Nordisk on Robotic Process Automation resulting in a discussion to explore how safety systems can be effectively augmented to improve process efficiencies.

Upcoming Events

We are delighted to be able to share our calendar of network forums for Spring, 2019 as detailed below. For further information please contact This email address is being protected from spambots. You need JavaScript enabled to view it.
UK events, London
  • pvnet – 21 May, 2019
  • pvtech – 21 May, 2019
  • pvconnect – 22 May, 2019
  • rimnet - 22 May, 2019
  • labelnet – 23 May, 2019
  • labelconnect – 23 May, 2019
  • labeltech – 24 May, 2019
USA Events, New York
  • pvnet – 04 June, 2019
  • rimnet - 04 June, 2019
  • pvtech – 05 June, 2019
  • labelnet – 05 June, 2019
  • labelconnect –05 June, 2019
  • labeltech – 06 June, 2019
  • pvconnect – 06 June, 2019

Latest News

21
May2019

Navitas Life Sciences announces acquisition of KAI Research, US-based full-service Contract Research Organisation (CRO)

Navitas Life Sciences, a TAKE Solutions Enterprise today announced the acquisition of US based...

13
Feb2019

Navitas Life Sciences announces acquisition of DataCeutics Inc. to augment global Clinical Data Science Services

Navitas Life Sciences, a TAKE Solutions Enterprise today announced that it will be acquiring...